The global market for iPSC Derived Cell Drugs was valued at US$ 219 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.5% during the forecast period.

iPSC Derived Cell Drugs Market

iPSC-derived cell drugs are drugs prepared using induced pluripotent stem cell (iPSC) technology. iPSCs are obtained by introducing specific transcription factors into somatic cells to reprogram them into pluripotent stem cells. These pluripotent stem cells have the potential to differentiate into various cell types and can therefore be used to prepare cell drugs for the treatment of specific diseases. iPSC-derived cell drugs have broad application prospects in the treatment of degenerative diseases, tissue repair, and other areas. By directing the differentiation of iPSCs into specific types of cells, such as neurons and cardiomyocytes, personalized cell replacement therapies can be provided to patients, thereby restoring the function of damaged tissues.

North American market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for iPSC Derived Cell Drugs in Anti-Inflammatory Repair is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of iPSC Derived Cell Drugs include Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for iPSC Derived Cell Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding iPSC Derived Cell Drugs.

The iPSC Derived Cell Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global iPSC Derived Cell Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the iPSC Derived Cell Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of iPSC Derived Cell Drugs Market Report

Report Metric	Details
Report Name	iPSC Derived Cell Drugs Market
Accounted market size in year	US$ 219 million
Forecasted market size in 2031	US$ 309 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Autologous iPSC Derived Cell Drugs Universal iPSC Derived Cell Drugs
Segment by Application	Anti-Inflammatory Repair Tumor Immunity Regenerative Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of iPSC Derived Cell Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is iPSC Derived Cell Drugs Market growing?

Ans: The iPSC Derived Cell Drugs Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the iPSC Derived Cell Drugs Market size in 2031?

Ans: The iPSC Derived Cell Drugs Market size in 2031 will be US$ 309 million.

Who are the main players in the iPSC Derived Cell Drugs Market report?

Ans: The main players in the iPSC Derived Cell Drugs Market are Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart

What are the Application segmentation covered in the iPSC Derived Cell Drugs Market report?

Ans: The Applications covered in the iPSC Derived Cell Drugs Market report are Anti-Inflammatory Repair, Tumor Immunity, Regenerative Medicine, Others

What are the Type segmentation covered in the iPSC Derived Cell Drugs Market report?

Ans: The Types covered in the iPSC Derived Cell Drugs Market report are Autologous iPSC Derived Cell Drugs, Universal iPSC Derived Cell Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global iPSC Derived Cell Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Autologous iPSC Derived Cell Drugs

1.2.3 Universal iPSC Derived Cell Drugs

1.3 Market by Application

1.3.1 Global iPSC Derived Cell Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Anti-Inflammatory Repair

1.3.3 Tumor Immunity

1.3.4 Regenerative Medicine

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global iPSC Derived Cell Drugs Market Perspective (2020-2031)

2.2 Global iPSC Derived Cell Drugs Growth Trends by Region

2.2.1 Global iPSC Derived Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 iPSC Derived Cell Drugs Historic Market Size by Region (2020-2025)

2.2.3 iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031)

2.3 iPSC Derived Cell Drugs Market Dynamics

2.3.1 iPSC Derived Cell Drugs Industry Trends

2.3.2 iPSC Derived Cell Drugs Market Drivers

2.3.3 iPSC Derived Cell Drugs Market Challenges

2.3.4 iPSC Derived Cell Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top iPSC Derived Cell Drugs Players by Revenue

3.1.1 Global Top iPSC Derived Cell Drugs Players by Revenue (2020-2025)

3.1.2 Global iPSC Derived Cell Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Top iPSC Derived Cell Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by iPSC Derived Cell Drugs Revenue

3.4 Global iPSC Derived Cell Drugs Market Concentration Ratio

3.4.1 Global iPSC Derived Cell Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by iPSC Derived Cell Drugs Revenue in 2024

3.5 Global Key Players of iPSC Derived Cell Drugs Head office and Area Served

3.6 Global Key Players of iPSC Derived Cell Drugs, Product and Application

3.7 Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 iPSC Derived Cell Drugs Breakdown Data by Type

4.1 Global iPSC Derived Cell Drugs Historic Market Size by Type (2020-2025)

4.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031)

5 iPSC Derived Cell Drugs Breakdown Data by Application

5.1 Global iPSC Derived Cell Drugs Historic Market Size by Application (2020-2025)

5.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America iPSC Derived Cell Drugs Market Size (2020-2031)

6.2 North America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America iPSC Derived Cell Drugs Market Size by Country (2020-2025)

6.4 North America iPSC Derived Cell Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe iPSC Derived Cell Drugs Market Size (2020-2031)

7.2 Europe iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025)

7.4 Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific iPSC Derived Cell Drugs Market Size (2020-2031)

8.2 Asia-Pacific iPSC Derived Cell Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America iPSC Derived Cell Drugs Market Size (2020-2031)

9.2 Latin America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025)

9.4 Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa iPSC Derived Cell Drugs Market Size (2020-2031)

10.2 Middle East & Africa iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Shanghai UniXell Biotechnology

11.1.1 Shanghai UniXell Biotechnology Company Details

11.1.2 Shanghai UniXell Biotechnology Business Overview

11.1.3 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Introduction

11.1.4 Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.1.5 Shanghai UniXell Biotechnology Recent Development

11.2 HELP Therapeutics

11.2.1 HELP Therapeutics Company Details

11.2.2 HELP Therapeutics Business Overview

11.2.3 HELP Therapeutics iPSC Derived Cell Drugs Introduction

11.2.4 HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.2.5 HELP Therapeutics Recent Development

11.3 Hopstem Biotechnology

11.3.1 Hopstem Biotechnology Company Details

11.3.2 Hopstem Biotechnology Business Overview

11.3.3 Hopstem Biotechnology iPSC Derived Cell Drugs Introduction

11.3.4 Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.3.5 Hopstem Biotechnology Recent Development

11.4 Nuwacell

11.4.1 Nuwacell Company Details

11.4.2 Nuwacell Business Overview

11.4.3 Nuwacell iPSC Derived Cell Drugs Introduction

11.4.4 Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.4.5 Nuwacell Recent Development

11.5 Allele Biotech

11.5.1 Allele Biotech Company Details

11.5.2 Allele Biotech Business Overview

11.5.3 Allele Biotech iPSC Derived Cell Drugs Introduction

11.5.4 Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.5.5 Allele Biotech Recent Development

11.6 BlueRock Therapeutics

11.6.1 BlueRock Therapeutics Company Details

11.6.2 BlueRock Therapeutics Business Overview

11.6.3 BlueRock Therapeutics iPSC Derived Cell Drugs Introduction

11.6.4 BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.6.5 BlueRock Therapeutics Recent Development

11.7 Century Therapeutics

11.7.1 Century Therapeutics Company Details

11.7.2 Century Therapeutics Business Overview

11.7.3 Century Therapeutics iPSC Derived Cell Drugs Introduction

11.7.4 Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.7.5 Century Therapeutics Recent Development

11.8 Fate Therapeutics

11.8.1 Fate Therapeutics Company Details

11.8.2 Fate Therapeutics Business Overview

11.8.3 Fate Therapeutics iPSC Derived Cell Drugs Introduction

11.8.4 Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.8.5 Fate Therapeutics Recent Development

11.9 Cellino

11.9.1 Cellino Company Details

11.9.2 Cellino Business Overview

11.9.3 Cellino iPSC Derived Cell Drugs Introduction

11.9.4 Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.9.5 Cellino Recent Development

11.10 Xellsmart

11.10.1 Xellsmart Company Details

11.10.2 Xellsmart Business Overview

11.10.3 Xellsmart iPSC Derived Cell Drugs Introduction

11.10.4 Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025)

11.10.5 Xellsmart Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

BlueRock Therapeutics

Century Therapeutics

Fate Therapeutics

Cellino

Shanghai UniXell Biotechnology

Hopstem Biotechnology

Xellsmart

List of Tables

Table 1. Global iPSC Derived Cell Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Autologous iPSC Derived Cell Drugs

Table 3. Key Players of Universal iPSC Derived Cell Drugs

Table 4. Global iPSC Derived Cell Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global iPSC Derived Cell Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global iPSC Derived Cell Drugs Market Share by Region (2020-2025)

Table 8. Global iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global iPSC Derived Cell Drugs Market Share by Region (2026-2031)

Table 10. iPSC Derived Cell Drugs Market Trends

Table 11. iPSC Derived Cell Drugs Market Drivers

Table 12. iPSC Derived Cell Drugs Market Challenges

Table 13. iPSC Derived Cell Drugs Market Restraints

Table 14. Global iPSC Derived Cell Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global iPSC Derived Cell Drugs Market Share by Players (2020-2025)

Table 16. Global Top iPSC Derived Cell Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Derived Cell Drugs as of 2024)

Table 17. Ranking of Global Top iPSC Derived Cell Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by iPSC Derived Cell Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of iPSC Derived Cell Drugs, Headquarters and Area Served

Table 20. Global Key Players of iPSC Derived Cell Drugs, Product and Application

Table 21. Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global iPSC Derived Cell Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global iPSC Derived Cell Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific iPSC Derived Cell Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Shanghai UniXell Biotechnology Company Details

Table 47. Shanghai UniXell Biotechnology Business Overview

Table 48. Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Product

Table 49. Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 50. Shanghai UniXell Biotechnology Recent Development

Table 51. HELP Therapeutics Company Details

Table 52. HELP Therapeutics Business Overview

Table 53. HELP Therapeutics iPSC Derived Cell Drugs Product

Table 54. HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 55. HELP Therapeutics Recent Development

Table 56. Hopstem Biotechnology Company Details

Table 57. Hopstem Biotechnology Business Overview

Table 58. Hopstem Biotechnology iPSC Derived Cell Drugs Product

Table 59. Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 60. Hopstem Biotechnology Recent Development

Table 61. Nuwacell Company Details

Table 62. Nuwacell Business Overview

Table 63. Nuwacell iPSC Derived Cell Drugs Product

Table 64. Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 65. Nuwacell Recent Development

Table 66. Allele Biotech Company Details

Table 67. Allele Biotech Business Overview

Table 68. Allele Biotech iPSC Derived Cell Drugs Product

Table 69. Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 70. Allele Biotech Recent Development

Table 71. BlueRock Therapeutics Company Details

Table 72. BlueRock Therapeutics Business Overview

Table 73. BlueRock Therapeutics iPSC Derived Cell Drugs Product

Table 74. BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 75. BlueRock Therapeutics Recent Development

Table 76. Century Therapeutics Company Details

Table 77. Century Therapeutics Business Overview

Table 78. Century Therapeutics iPSC Derived Cell Drugs Product

Table 79. Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 80. Century Therapeutics Recent Development

Table 81. Fate Therapeutics Company Details

Table 82. Fate Therapeutics Business Overview

Table 83. Fate Therapeutics iPSC Derived Cell Drugs Product

Table 84. Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 85. Fate Therapeutics Recent Development

Table 86. Cellino Company Details

Table 87. Cellino Business Overview

Table 88. Cellino iPSC Derived Cell Drugs Product

Table 89. Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 90. Cellino Recent Development

Table 91. Xellsmart Company Details

Table 92. Xellsmart Business Overview

Table 93. Xellsmart iPSC Derived Cell Drugs Product

Table 94. Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)

Table 95. Xellsmart Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. iPSC Derived Cell Drugs Picture

Figure 2. Global iPSC Derived Cell Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global iPSC Derived Cell Drugs Market Share by Type: 2024 VS 2031

Figure 4. Autologous iPSC Derived Cell Drugs Features

Figure 5. Universal iPSC Derived Cell Drugs Features

Figure 6. Global iPSC Derived Cell Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global iPSC Derived Cell Drugs Market Share by Application: 2024 VS 2031

Figure 8. Anti-Inflammatory Repair Case Studies

Figure 9. Tumor Immunity Case Studies

Figure 10. Regenerative Medicine Case Studies

Figure 11. Others Case Studies

Figure 12. iPSC Derived Cell Drugs Report Years Considered

Figure 13. Global iPSC Derived Cell Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global iPSC Derived Cell Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global iPSC Derived Cell Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global iPSC Derived Cell Drugs Market Share by Players in 2024

Figure 17. Global iPSC Derived Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by iPSC Derived Cell Drugs Revenue in 2024

Figure 19. North America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 21. United States iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 25. Germany iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific iPSC Derived Cell Drugs Market Share by Region (2020-2031)

Figure 33. China iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 41. Mexico iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa iPSC Derived Cell Drugs Market Share by Country (2020-2031)

Figure 45. Turkey iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Shanghai UniXell Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 49. HELP Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 50. Hopstem Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 51. Nuwacell Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 52. Allele Biotech Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 53. BlueRock Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 54. Century Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 55. Fate Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 56. Cellino Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 57. Xellsmart Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Induced Pluripotent Stem Cells iPSCs Market Insights Forecast to 2030

Global IPS Cell derived Platelets Market Research Report 2025

Global iPSC Kit Market Research Report 2025

Global Induced Pluripotent Stem Cells Service Market Research Report 2024

Global Human Induced Pluripotent Stem Cells iPSCs Market Research Report 2024

Global iPSC Generation Kit Market Research Report 2025

Global Induced Pluripotent Stem Cells iPSCs Culture Medium Market Research Report 2024

Global IPS Cell Differentiation Kit Market Research Report 2025

Global iPSC Differentiation Kit Market Research Report 2025

Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Research Antibodies Market Research Report 2024

Global Universal Cell Therapy Drug Market Research Report 2024

Global iPSC Characterization Kit Market Research Report 2025

Global Personalized Cell Therapy Market Research Report 2024

Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025

Global Human iPS Cell Characterization Kit Market Research Report 2025

Global iPSCs Expansion Medium Market Research Report 2024

Global Induced Pluripotent Stem Cells Production Market Research Report 2025

Global Human Embryonic Stem Cells HESC Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions